Keywords: عوامل رمان; Hemophilia A; Factor VIII inhibitor; Inhibitor by passing activity; Activated prothrombin concentrate; Recombinant activated factor VII; Factor VIII; Novel agents; TFPI antagonists; ATIII antagonist; Concizumab; Emicizumab; Alpha 1 antitrypsin;
مقالات ISI عوامل رمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوامل رمان; Sickle cell disease; Adhesion pathway; Inflammation; Novel agents;
Keywords: عوامل رمان; Mantle-cell lymphoma; Novel agents; Transplantation; Prognostic factors;
Keywords: عوامل رمان; Multiple myeloma; Allogeneic transplantation; Novel agents; Graft-versus-myeloma effect;
Keywords: عوامل رمان; Monoclonal antibody; Novel agents; Radioimmunotherapy; Transformed lymphoma; Treatment outcome;
Keywords: عوامل رمان; Hodgkin lymphoma; novel agents; PET-CT scanning;
Keywords: عوامل رمان; Aggressive; Classification; immuno-chemotherapy; indolent; non-Hodgkin lymphoma; novel agents; prognosis;
Keywords: عوامل رمان; CAD, coronary artery disease; CCBs, calcium channel blockers; ESC, European Society of Cardiology; AHA, American Heart AssociationRefractory angina; Pharmacotherapy; Novel agents
Keywords: عوامل رمان; AML; Molecular targets; Novel agents; Outcome; Relapse;
Keywords: عوامل رمان; Conventional chemotherapy; High Dose Therapy; Maintenance therapy; Novel agents; Transplant Eligible
Keywords: عوامل رمان; Diffuse Large B-cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Novel Agents; Peripheral T-cell Lymphoma;
Keywords: عوامل رمان; Bladder cancer; Clinical trials; Immune checkpoints; Novel agents; Targeted therapy;
Keywords: عوامل رمان; Multiple myeloma; Novel agents; Radiation; Safety; Toxicity
Keywords: عوامل رمان; Multiple myeloma; Elderly patients; Novel agents; Therapy;
Keywords: عوامل رمان; Chemosensitive disease; Complete response; Novel Agents; Serum M protein; Transplant outcome;
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome
Keywords: عوامل رمان; Primary plasma cell leukemia; Multiple myeloma; Novel agents; Immunomodulatory drugs (IMiDs);
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
Keywords: عوامل رمان; Multiple myeloma; Newly diagnosed; Continuous therapy; High risk; Novel agents;
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome
Keywords: عوامل رمان; Cutaneous; T cell; Lymphoma; Sézary; Novel agents; Biological agents;
Non-PCI/CABG therapies for refractory angina
Keywords: عوامل رمان; Refractory angina; Pharmacologic therapy; Non-pharmacologic therapy; Novel agents; Cardiac rehabilitation; Enhanced external counterpulsation;
Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults
Keywords: عوامل رمان; Acute myeloid leukemia; Older adults; Induction chemotherapy; Hypomethylating agents; Novel agents;
Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab into Clinical Practice
Keywords: عوامل رمان; Anti-CD20 antibody; BTK inhibitor; Lymphoid malignancy; Novel agents; PI3K inhibitor
Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy
Keywords: عوامل رمان; Acute myeloid leukemia (AML); Combination; Low-intensity; Newly diagnosed; Novel agents; Older/elderly;
Positron Emission Tomography With Computed Tomography-Based Diagnosis of Massive Extramedullary Progression in a Patient With High-Risk Multiple Myeloma
Keywords: عوامل رمان; Extramedullary disease; Multiple myeloma; Novel agents; PET/CT; Prognosis;
Néphropathie diabétique : traitements émergents
Keywords: عوامل رمان; Agents nouveaux; Diabète sucré; Maladie rénale chronique; Traitement de la néphropathie diabétiqueChronic kidney disease; Diabetes mellitus; Diabetic nephropathy therapy; Novel agents
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
Keywords: عوامل رمان; Neoadjuvant breast cancer; Pathological complete response; Trastuzumab; Lapatinib; Pertuzumab; Novel agents; HER2;
Hodgkin lymphoma
Keywords: عوامل رمان; Hodgkin lymphoma; novel agents; PET/CT scanning
Disease control in patients with relapsed and/or refractory multiple myeloma: what is the optimal duration of therapy?
Keywords: عوامل رمان; Continuous treatment; Duration of therapy; Long-term treatment; Multiple myeloma; Novel agents; Relapsed/refractory; Re-treatment
Novel agents in mantle cell lymphoma
Keywords: عوامل رمان; mantle cell lymphoma; novel agents; B cell receptor
Treatment of relapsed and refractory multiple myeloma in the era of novel agents
Keywords: عوامل رمان; Multiple myeloma; Relapse treatment; Refractory disease; Guidelines; Novel agents; Lenalidomide; Bortezomib; Thalidomide
Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG
Keywords: عوامل رمان; Bladder cancer; Intravesical; BCG-refractory; Novel agents; Cystectomy
Novel agents for B-cell non-Hodgkin lymphoma: Science and the promise
Keywords: عوامل رمان; Drug targets; Lymphoma; Novel agents; Small molecules; Immunotherapy
Recent Progress in the Treatment of Acute Lymphoblastic Leukemia: Clofarabine
Keywords: عوامل رمان; Acute lymphoblastic leukemia therapy; Novel agents; Nucleoside analogs; Relapsed acute lymphoblastic leukemia; High-risk acute lymphoblastic leukemia;
Development of novel agents for bladder cancer
Keywords: عوامل رمان; Bladder Cancer; Novel Agents; Chemotherapy; Angiogenesis; Epigenetics; HER-2; EGFR; NFκB; PI3 kinase; Clinical Trial Design
New drug development in metastatic prostate cancer
Keywords: عوامل رمان; Drug development; Prostate cancer; Hormone refractory; Novel agents; Chemotherapy; Angiogenesis; mTOR; Immunotherapy; Vitamin D; HDAC inhibitors; Castration-resistant
Novel treatment options for refractory germ cell tumors
Keywords: عوامل رمان; Germ cell tumors; Salvage therapy; Novel agents
Exploring the role of novel agents in the treatment of renal cell carcinoma
Keywords: عوامل رمان; Renal cell carcinoma; Nephrectomy; Novel agents
The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer
Keywords: عوامل رمان; Hypoxia; Childhood cancer; Novel agents
Frontline treatment in multiple myeloma patients not eligible for stem-cell transplantation
Keywords: عوامل رمان; elderly patients; novel agents; multiple myeloma
Role of autologous stem-cell transplantation in multiple myeloma
Keywords: عوامل رمان; multiple myeloma; high-dose therapy; autologous stem-cell transplantation; double transplantation; novel agents; thalidomide; bortezomib; lenalidomide; induction; maintenance
Management of multiple myeloma: The changing landscape
Keywords: عوامل رمان; Multiple myeloma; Autologous stem cell transplantation; Novel agents
Novel cytotoxic and biological agents for prostate cancer: Where will the money be in 2005?
Keywords: عوامل رمان; Prostate cancer; Chemotherapy; Targeted therapy; Novel agents;